DarioHealth Corp. announced an agreement with a global company based in the United States to provide its integrated digital health management solution for diabetes, hypertension, and musculoskeletal (MSK) health. The contract is expected to launch in the first quarter of 2022. Significant overlap exists between metabolic conditions like diabetes and musculoskeletal health; more than a third of people living with diabetes also experience musculoskeletal pain. The Company selected Dario to provide a highly personalized approach to chronic condition management to help improve employee health and reduce the cost of care. Dario's digital therapeutic platform integrates digital tools, medical devices, and digital and human coaching across one experience, delivering a seamless user journey for employees to help them change their behavior to better manage their chronic conditions.